A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease

Clinical trial NCT06702124 · RECRUITING

Trial details

NCT number: NCT06702124
Sponsor: I.R.C.C.S. Fondazione Santa Lucia
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2023-12-01
Primary completion: 2025-07-01
Enrollment: 348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.